Completed all preclinical studies and manufacturing to support PMN310 IND submission to U.S. Food and Drug Administration
Preclinical data that further characterize ongoing programs, including PMN310, to be presented
"Fast Forward" Strategy to Deliver $800 million in Net Sales and $100 million Adjusted EBITDA by FY28
LSI Industries Inc. (NASDAQ:LYTS, ", LSI", or the ", Company", )))) a
Crane NXT on Track to Become an Independent Company on April 3, 2023
Crane NXT, which is on track to become an independent company on April 3, 2023, following completion of Crane Holdings, Co.'s previously announced
Asana Inc (NYSE: ASAN) shares are moving higher in after hours Wednesday after the company reported better-than-expected financial results and issued strong guidance.
Fiscal 2023 Outlook
The Company is providing initial guidance ranges for net sales and adjusted EBITDA1, as follows:
Net sales
$900-$925 million
Adjusted EBITDA
$130-$135
First Quarter 2023 Outlook
For the first quarter of 2023, the company is projecting total revenue to be between flat and a decline of 2% from the first quarter 2022 total revenue